Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financi...(- --------- Total current l...)

Date:8/7/2009

- --------- Total current liabilities 470,945 1,430,117 Accrued expenses and other liabilities, non-current 36,420 42,636 ------ ------ Total liabilities 507,365 1,472,753 Total stockholders' equity 5,973,933 10,560,215 --------- ---------- Total liabilities and stockholders' equity $6,481,298 $12,032,968 ========== ===========

'/>"/>

SOURCE Catalyst Pharmaceutical Partners, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7
Related biology technology :

1. Using catalysts to stamp nanopatterns without ink
2. Experiments reveal unexpected activity of fuel cell catalysts
3. UCT Specialties (Formerly Petrarch) Announces the Release of Their New Product Guides for Silanes, Silicones, Platinum Catalyst and Glass Coatings
4. IDEXX Laboratories Announces First Customer Deliveries of Catalyst Dx(TM) Chemistry Analyzer and SNAPshot Dx(TM) Analyzer
5. Catalyst Pharmaceutical Partners, Inc. Files Form S-3 Shelf Registration Statement
6. Controlling the size of nanoclusters: First step in making new catalysts
7. Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
8. NIST and partners identify tiny gold clusters as top-notch catalysts
9. Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering
10. Catalyst Pharmaceutical Partners to Present at the Rodman & Renshaw 10th Annual Global Investment Conference
11. PointCross Releases Catalyst for Building Business-Ready SharePoint Solutions in 1/10th the Time